Gavin M. Bendle
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Enabling next-generation engineered TCR-T therapies based on high-throughput TCR discovery from diagnostic tumor biopsies.
Journal: Nature communications
Published: September 09, 2024
The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: May 05, 2022
Safety and efficacy of Tet-regulated IL-12 expression in cancer-specific T cells.
Journal: Oncoimmunology
Published: July 26, 2018
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers.
Journal: Nature medicine
Published: May 08, 2018
Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies.
Journal: Journal for immunotherapy of cancer
Published: March 13, 2018
Adoptive T-cell therapy for cancer in the United kingdom: a review of activity for the British Society of Gene and Cell Therapy annual meeting 2015.
Journal: Human gene therapy
Published: April 11, 2015
Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity.
Journal: Cancer research
Published: November 25, 2014
RNAi-mediated TCR knockdown prevents autoimmunity in mice caused by mixed TCR dimers following TCR gene transfer.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 08, 2013
Blockade of TGF-β signaling greatly enhances the efficacy of TCR gene therapy of cancer.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 14, 2013
High-throughput identification of antigen-specific TCRs by TCR gene capture.
Journal: Nature medicine
Published: April 12, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026